Jay Venkatesan Angion's guest appearances

Jay Venkatesan Angion

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Dr. Jay Venkatesan, CEO, Angion, a clinical stage biopharmaceutical company, discusses the company's work in organ self-repair and their initial focus in the nephrology space.  The company's lead candidate ANG-3777 is a small molecule that mimics a protein to stimulate this self-repair and regeneration following injury. Angion's therapeutic programs modulate the natural repair pathways of the body to fill unmet medical needs across many indications, including acute kidney injury, kidney transplantation, and chronic kidney disease. #organinjury  #organtransplant  #acutekidneyinjury #chronickidneydisease Angion

Dr. Jay Venkatesan, CEO, Angion, a clinical stage biopharmaceutical company, discusses the company's work in organ self-repair and their initial focus in the nephrology space.  The company's lead candidate ANG-3777 is a small molecule that mimics a protein to stimulate this self-repair and regeneration following injury. Angion's therapeutic programs modulate the natural repair pathways of the body to fill unmet medical needs across many indications, including acute kidney injury, kidney transplantation, and chronic kidney disease. #organinjury  #organtransplant  #acutekidneyinjury #chronickidneydisease <a href="http://angion.com" rel="noopener nofollow" target="_blank">Angion</a>

Organ Self-Repair from Injury and Disease with Dr. Jay Venkatesan Angion